Patients on Ozempic report ‘waking up blind’ in as little as a day after using fat jab
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported terrifying changes to their vision mere days or weeks after taking the ...
Super Bowl ad on weight loss drugs calls out America’s ‘broken’ health care; Senators express concern
A controversial Super Bowl ad by Hims & Hers targets America's obesity epidemic and criticizes the healthcare system. The ad ...
Shein’s London listing at risk as Trump plans US tax changes
Shein and other fast fashion companies could be heavily impacted by new tax changes in the US, which could close a key ...
Mint13d
Are weight-loss drugs like gym memberships? The answer is worth billions
If obesity is a chronic disease, like kidney or heart conditions, demand for GLP-1 drugs shouldn’t ebb and flow with the seasons. But the weight-loss market is far from typical. After analyzing ...
India TV13d
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really bummed out’
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...
STAT13d
‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs
A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...
US FDA approves Novo Nordisk's diabetes drug to reduce risk of worsening kidney disease
Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with type 2 diabetes ...
NBC Washington14d
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...
E!15d
Josh Gad Reveals He’s Lost 40-Lbs. After Taking Weight Loss Medication
But even so, the Wedding Ringer actor made it clear that isn’t losing ... Turner adding her own commentary, writing, "WTF." Ozempic maker Novo Nordisk previously told E! News that the drug ...